Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Mercaptopurine tablets | ESCA |
|
|
Meritene shake (powder) | Prescribed for liver patients at request of UHB liver/dietetic team only. Liver/hepatobiliary and pancreatic conditions. Supported by RICaD. |
|
|
Mesalazine (Octasa®) | Octasa is preferred brand of choice |
|
|
Metanium ointment | ||
|
Methadone hydrochloride | Palliative care only |
|
|
Methadone mixture 1mg/ml | ||
|
Methotrexate | ILD - ESCA |
|
|
Methotrexate 2.5mg tablets | Supported with an ESCA. Methotrexate tablets - use 2.5mg strength ONLY. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
Methotrexate injections | Supported with an ESCA. Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
|
|
Methotrexate tablets (2.5mg) | ESCA. Methotrexate tablets - use 2.5mg strength only. Methotrexate injection - Metoject is APC preferred brand. Check cytotoxic disposal arrangements locally. |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
